What is adaptive Biotechnologies?

SEATTLE, May 04, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 3...

Who owns adaptive biotech?

Harlan Robins, Adaptive's chief scientific officer, and his brother, CEO Chad Robins, co-founded the biotech in 2009. The company focuses on immune system technology, and it offers products in diagnostics and life sciences research. Adaptive also developed a T-cell-based test for Covid-19.

Why is adaptive Biotechnologies expanding its executive leadership team?

“We are excited to further expand our executive leadership team as we scale our organization and accelerate the development and commercialization of clinical products stemming from our immune medicine platform,” said Chad Robins, CEO and co-founder of Adaptive Biotechnologies.